Skip to Content

Masimo (NASDAQ:MASI) shares surge after an analyst upgrade.

Masimo (NASDAQ:MASI) shares surge after an analyst upgrade.

Before trading on Wednesday, Stifel Nicolaus raised their price objective on Masimo Co. (NASDAQ: MASI) from $164.00 to $170.00. The price of one share of stock was $170.99 when trading began for the day, and it finished at $153.45. 4,406 Masimo shares changed hands during the most recent transaction, which took place for $156.92 per share.

Additionally, MASI has been discussed in a wide variety of other reports that have been published. In a research report released by Needham & Company LLC on Monday, December 5, the company upgraded Masimo from a “hold” rating to a “buy” rating and raised its price objective on the stock from $149.00 to $173.00. Additionally, the company raised its price target for the stock from $149.00 to $173.00. In a research note that was made public on October 12, Jefferies Financial Group announced that the firm would begin providing coverage of Masimo’s shares. They suggested investing in the company’s stock and setting a price objective of $180 per share. On September 13, Loop Capital published a research note on Masimo shares, which was also the first day it covered the company. They suggested investing in the company’s shares and determined that a price target of $206.00 was appropriate. Wolfe Research upgraded shares of Masimo from a “peer perform” rating to an “outperform” rating and set a price objective of $165.00 on the company in a research note published on Thursday, September 15. StockNews.com released a research report on Masimo’s shares on October 12; this publication marked the beginning of the website’s coverage of the company’s stock. They advised their clients to “hold” the stock moving forward. Only two of the research experts surveyed suggested that investors keep their existing holdings in the security, while seven recommended that investors buy the stock. According to Bloomberg.com, the current average recommendation for the company’s stock is a “Moderate Buy,” The website’s consensus price goal for the business is $188.00. This information was derived from user votes on the website.

On November 14, the Chief Executive Officer of the company, Joe E. Kiani, purchased 31,994 shares of the company’s stock. Other recent developments include the following: The total number of shares purchased was 3,966,936.06, which resulted in an average cost per share of $123.99 for the transaction. Following the successful conclusion of the transaction, the Chief Executive Officer now owns 39,778 company shares, the total value of which is 4,932,074.22 dollars. The acquisition was reported in a document handed into the SEC, and that document is now available on the website of the SEC. Joe E. Kiani, the company’s Chief Executive Officer, purchased 31,994 shares of the company’s stock on November 14, according to additional information related to this topic that was recently made public. The total amount spent on purchasing the shares was $3,966,936.06, which totals an average price of $123.99 per share. After the completion of the acquisition, the chief executive officer now directly owns 39,778 shares of the company’s stock. The value of these shares is approximately 4,932,074.22 dollars. Should you follow this link, you will be taken to the SEC filing in which the transaction was discussed in greater detail. Masimo, Inc. Chief Executive Officer Joe E. Kiani purchased 7,040 shares of the company’s stock on December 15. This is in addition to the previous transaction. A total of $1,019,321.60 was spent on the acquisition of the stock, which works out to a price of $144.79 per share on an average basis. As a direct result of the transaction, the Chief Executive Officer now owns a total of 46,818 shares of the company, which have a value of approximately $6,778,778.22. You should look in this location if you are looking for the disclosure that pertains to this transaction. During the most recent three months, those with inside knowledge of a company’s operations purchased a total of 46,818 shares with a value of $5,992,495; People currently employed by the organization own 9.70% of the total number of shares issued by the company.

Several hedge funds and institutional investors have recently adjusted to the positions in MASI that they had previously held. During the third quarter of 2018, Politan Capital Management LP bought an additional 656,234,000 Masimo stock shares, bringing its holdings’ total value to $656,234,000. During the second quarter, Nomura Holdings, Inc. provided Masimo with a contribution of 242,537,00 dollars. Goldman Sachs Group Inc. increased the amount of Masimo stock owned by 92.1% during the second quarter of the fiscal year. Goldman Sachs Group Inc. now has a total of 856,664 shares of the medical equipment provider’s stock, following the purchase of an additional 410,793 shares during the most recent period. The stock currently has a total value of $111,940,000 due to Goldman Sachs Group Inc.’s ownership of these shares. The investment portfolio of Farallon Capital Management LLC increased by 195.9% during the third quarter as a result of the addition of additional shares of Masimo. After purchasing an additional 382,000 shares during the relevant period, Farallon Capital Management LLC now holds 577,000 of the medical equipment provider’s shares, which have a market value of $81,449,000. These shares were acquired due to the company’s purchase of additional shares during the period above. Last but certainly not least, during the second quarter, the Bank of Nova Scotia increased the percentage of Masimo stock that it held by 19,378.7%. This certainly should not be considered the least important development. The Bank of Nova Scotia now holds 305,037 shares of the medical equipment provider’s stock, which is $39,859,000. This is because the Bank of Nova Scotia purchased 303,471 shares during the relevant time period. Institutional investors and hedge funds hold the majority of the company’s common stock, accounting for 87.67% of the total shares outstanding.

The stock has been trading for $142.20 on average over the past 50 days, while its moving average price over the past 200 days is $140.49. The debt-to-equity ratio is 0.76, the current ratio is 2.12, and the quick ratio is 1.28. All three ratios are presented in their most recent forms. The company’s price-to-earnings ratio is 50.81, and its beta value is 0.86. The company’s total value, as measured by its market capitalization, is $8.26 billion.

Masimo, Inc. (NASDAQ: MASI) most recently disseminated a press release on Tuesday, November 8, containing their quarterly earnings. The medical equipment manufacturer reported earnings per share for the quarter of $1.00, which is $0.08 higher than the average prediction of analysts, which was $0.92. The sales for the company during the quarter came in at $549.30 million, which is significantly higher than the industry experts’ projection of $533.96 million for the company’s revenue during the period. Masimo had a return on equity of 18.044%, and the net margin for the company was 9.78%. Masimo Company is expected to generate earnings of $4.45 per share in the current fiscal year, according to the projections of the majority of industry analysts.

The Masimo Corporation is an industry leader in developing noninvasive monitoring technologies and the production, distribution, and installation of hospital automation systems worldwide. This company provides Masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to get around the most significant limitations of standard pulse oximetry.

Tags

Leave a comment

Your email address will not be published. Required fields are marked *